Christopher Viehbacher
![Sanofi, Biogen, Reata Pharmaceuticals, Christopher Viehbacher,](https://pharmtales.com/wp-content/uploads/2023/08/Bloomberg-Reports_-Sanofi-Fails-to-Secure-Reata-in-Bidding-Battle-Against-Biogen-Following-Horizon-Setback.jpg)
Sanofi Fails to Secure Reata in Bidding Battle Against Biogen Following Horizon Setback
Anika Sharma
Biogen’s pursuit of Reata, a rare disease company based in Texas, has unveiled a compelling narrative of corporate rivalry and ...